Incepta Pharmaceuticals Ltd is the forerunner of today’s pharmaceutical industry and one of the leading pharmaceutical companies of Bangladesh.
Our vision is to become a trusted healthcare company to ensure better health for everyone, everywhere. One of the leading Pharmaceuticals in Bangladesh.
22/09/2025
Walk-in Interview of Medical Promotion Officers (MPO).
Minimum Requirements: Age within 30 years & Graduation with science up to HSC
Date of Walk-In-Interview
Dhaka: 23th, 24th & 25th September, 2025
Rangpur & Rajshahi : 24th & 25th September, 2025
15/09/2025
আপনার Mucolyt এখন নতুন মোড়কে!!!
একই কার্যকারিতা, এখন আরও আধুনিক ফর্মুলেশন ও আকর্ষণীয় প্যাকেজিং এ।
13/09/2025
Updates on Testicular Cancer
07/09/2025
Public Health Ophthalmology in Bangladesh: Challenges and Paths to Success
02/09/2025
Walk-in interview of Medical Promotion Officers (MPO)
Minimum Requirements: Age within 30 years & Graduation with science up to HSC.
Date of Walk-In-Interview
Dhaka: 2nd , 3rd & 4th September, 2025
Rangpur & Rajshahi: 3rd & 4th September, 2025
30/08/2025
HEARTBREAK TO HEROICS: Cracking Cardiac Arrest
26/08/2025
Join in the webinar - 'OGSB monthly scientific seminar'
Be the first to know and let us send you an email when Incepta Pharmaceuticals Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Founded in 1999, Incepta Pharmaceuticals Ltd is the forerunner of today’s pharmaceutical industry and one of the leading pharmaceutical companies of Bangladesh. The company has a very large diversified manufacturing facility at Savar, located 35 km away from the center of the capital city of Dhaka. Incepta’s success came from the company’s state-of-the-art manufacturing facility, adherence to modern technology and production of innovative products that made Incepta a unique company in South-East Asia.
Along with the receival of UK-MHRA cGMP certificate, Incepta has established another state-of-the art manufacturing facility at Dhamrai with a target to get the US FDA accreditation. We are committed to become a global leader in health care and change millions of lives through providing access to safe, effective and affordable medicines and related health care services to the people who need them. Incepta is currently manufacturing a range of bio-tech products including
Human Insulin, Erythropoietin, Filgrastim, Vaccine etc. along with regular chemical molecules.
Incepta is managed and lead by a dedicated and highly qualified team of professionals. As a company, we strive to maintain high ethical standards and a culture that value honesty, integrity and transparency in all levels. Guided by its brand statement, “Innovative Concept into Practice”, Incepta develops, manufactures and markets medicine to address the unmet medical needs of doctors’ community.
Now Incepta has gone beyond the boundary of Bangladesh.
One of our greatest achievements in 2015 is to introduce the first-ever generic in the world like Sofosbuvir (brand name Hopetavir) and Sofosbuvir+Ladipasvir (brand name Twinvir). Incepta is currently exporting medicines to 54 countries and is registering its products to about 30 more countries where we are expecting to export our products in near future.
Our vision is to become a trusted healthcare company to ensure better health for everyone, everywhere.